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Abstract: The use of spinal cord stimulation (SCS) devices to treat chronic, refractory neuropathic pain continues to expand in application. While device-related complications have been
well described, inflammatory reactions to the components of these devices remain underreported.
In contrast, hypersensitivity reactions associated with other implanted therapies, such as endovascular and cardiac rhythm devices, have been detailed. The purpose of this case series is to
describe the clinical presentation and course of inflammatory reactions as well as the histology of
these reactions. All patients required removal of the entire device after developing inflammatory
reactions over a time course of 1–3 months. Two patients developed a foreign body reaction in
the lead insertion wound as well as at the implantable pulse generator site, with histology positive
for giant cells. One patient developed an inflammatory dermatitis on the flank and abdomen that
resolved with topical hydrocortisone. “In vivo” testing with a lead extension fragment placed
in the buttock resulted in a negative reaction followed by successful reimplantation of an SCS
device. Inflammatory reactions to SCS devices can manifest as contact dermatitis, granuloma
formation, or foreign body reactions with giant cell formation. Tissue diagnosis is essential,
and is helpful to differentiate an inflammatory reaction from infection. The role of skin patch
testing for 96 hours may not be suited to detect inflammatory giant cell reactions that manifest
several weeks post implantation.
Keywords: spinal cord stimulation, delayed inflammatory responses, foreign body giant cell
reactions, contact dermatitis

Spinal cord stimulation (SCS) has been used since the 1960s to treat chronic refractory
pain conditions. In particular, SCS has been extensively used to manage the painful
symptoms related to chronic lumbosacral radiculopathy following failed back surgery
syndrome and complex regional pain syndromes. Randomized controlled trials of
SCS for failed back surgery syndrome have reported favorable long-term results.1,2
Concurrently, there has been significant technologic advancement in the equipment for
SCS. Specifically, implanting physicians can offer patients rechargeable implantable
pulse generators, improved anchoring systems, and more stimulating lead contacts
to ensure coverage for paresthesia in painful somatic regions. Thus, there is more
widespread use of SCS therapy and acceptance among treating physicians.
Despite the positive findings and increasing experience of implanting physicians
using SCS therapy, complications remain a common occurrence. An analysis of the
available literature by Turner et al found that just over one third of patients have a
complication.3 Prospective data from a multicenter evaluation of SCS for failed back
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surgery syndrome showed a similar rate of complications,
even in the hands of experienced implanters.4 These adverse
events are usually lead migration, infection, lead breakage,
and unwanted stimulation.4,5 An allergic or immunologic/
inflammatory reaction to the system components is thought
to be rare, and has been estimated by Cameron to be 0.1%.5
However, the true incidence may be underestimated because
clinicians may fail to include it in the differential diagnosis,
attributing an inflammatory reaction of the soft tissue surrounding SCS components to infection. In addition, only
two articles detail the cutaneous reaction to the components
of SCS systems.6,7 The purpose of this paper is to detail the
presentation, clinical course, and histologic findings in three
patients with cutaneous reactions to spinal cord stimulator
equipment components.

Case 1
The patient was a 61-year-old male who, despite two previous
laminectomies, epidural injections, and multimodal analgesia
(oxycodone/acetaminophen, cyclobenzaprine, ibuprofen),
complained of severe pain secondary to left-sided chronic
lumbosacral radiculopathy. The pain was 9/10 in intensity,
located at his lower back on the left side with radiation down
his posterior thigh, behind his knee to his lateral leg, and to
the bottom of the sole of his foot. He had a past medical history of irritable bowel syndrome, squamous cell carcinoma of
the skin, gastroesophageal reflux disease, and depression. The
only reported allergy was to meperidine. Magnetic resonance
imaging revealed no evidence of spinal stenosis, foraminal
narrowing, or nerve root displacement, so he was implanted
with an SCS consisting of two eight-contact leads, two lead
extensions, and a rechargeable implantable pulse generator
(EON™, St Jude Medical Neuromodulation Division, Plano,
TX, USA) following a successful trial of 7 days.
He was seen one week after the operation and his wounds,
which included the abdomen for the generator, flank for
the extension, and back for lead insertion and anchoring,
were noted to be dry with intact incisions, and no erythema,
drainage, or tenderness. He was afebrile. At one month
post operation, the patient developed a left-sided rash on
his flank and abdomen, with no fevers or chills (Figure 1).
The stimulator was working well, providing up to 60% pain
relief. The incisions over his abdomen, flank, and back were
well healed. However, he had an area of erythema/dermatitis
that seemed to be localized to the area over the length of the
lead extensions connecting the implantable pulse generator
to the leads. The reaction did not involve the implantable
pulse generator site. It was noted that this rash appeared to
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Figure 1 Erythematous rash on the abdomen and flank (case 1) primarily overlying
the lead extensions.

be an area of reactive inflammation, as opposed to infection,
and he was diagnosed with a hypersensitivity reaction to the
implanted wires. He was given topical 1% hydrocortisone
cream and seen 7 days later, with resolution of the rash.
Forty-three days after implantation, the patient presented
with complaints concerning wound drainage. There was no
history of fall or trauma. The abdominal and flank incisions
had dehisced, with device exposure and were draining pink,
clear fluid. He was afebrile, with only mild tenderness of
the wounds. His white blood cell count was 6.8 and the
differential was abnormal for eosinophils at 5.4%, with no
bandemia or elevation in fraction of neutrophils. Because
of concerns for potential early infection, urgent explantation of the entire SCS device was performed. Exploration
of the wounds did not reveal any purulent material, but the
subcutaneous tissue directly involving the wound was frail,
bled easily with manipulation, and was difficult to coagulate.
A tissue biopsy was taken from the lead extension site
(Figure 2). Once cultures were sent, the patient was started
on empiric vancomycin and ceftazidime.
Wound cultures were positive for rare coagulase negative
Staphylococci as well as rare Staphylococcus aureus, and the
patient was treated for 2 weeks with intravenous vancomycin.
Clinically, however, he did not manifest with the usual clinical findings suggestive of device infection. One month later,
all incisions were well healed. Because the initial reaction to
the SCS equipment involved the flank to the abdomen but
not the back, the buttock was targeted as a potential site for
the implantable pulse generator. In an attempt to rule out a
hypersensitivity reaction, an in vivo allergy test using a portion of the extension lead was done (Figure 3). A 4 cm lead
extension piece was placed in the left buttock via a 12 gauge
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Figure 2 Histopathology of soft tissue removed from the lead extension wound at
the flank (case 1). Light microscopy revealed granulation tissue, necrotic debris, and
fibrin with acute and chronic inflammation. No giant cell reaction was seen.

angiocatheter upon removal of the introducer. The extension
fragment was placed into the catheter which was removed
leaving the lead in the subcutaneous tissue. The puncture
site was closed with 4.0 Monocryl™ suture (Ethicon Inc,
Somerville, NJ, USA). After a 2-month follow-up period,
there was no cutaneous reaction to the lead extension.
One month later, the system was reimplanted, with the pulse
generator pocket site now in the left buttock. The patient tolerated the procedure well and had no postoperative complications.
Now three years following reimplantation, his pain is well
managed with a combination of SCS and medications.

Case 2
The patient was a 44-year-old gentleman with a past surgical history of decompression laminotomy, discectomy, and

Figure 3 The distal 4 cm of the lead extension pictured above was inserted via a
12 gauge angiocatheter into the subcutaneous tissue of the left buttock in case 1
for in vivo testing.
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fusion at L5/S1. One year following the surgery, the patient
continued to have worsening low back pain, with radiation
down his lateral calf into the lateral aspect of his dorsal foot.
The patient described the pain as being 8/10 in severity, with
an achy quality that was partially alleviated with oxycodone/
acetaminophen. He had a past history of depression and
colitis, and had no known drug allergies. Magnetic resonance imaging had revealed prior posterior decompression
of posterior fusion at the L5/S1 level with metallic hardware
artifacts with grade 1 anterolisthesis with posterior uncovering of the disc and superimposed left paracentral protrusion.
There was also enhancing tissue encasing the thecal sac and
the S1 nerve roots at the L5–S1 level.
The patient had no sustained improvement with transforaminal epidural injections. Following a one-week trial
of SCS, he reported excellent relief and was subsequently
implanted with dual eight-contact leads and the implantable EON™ pulse generator was placed in the left buttock
region. After two weeks, the patient complained of increased
pain from the mid back incision. On physical examination,
there was trace serosanguinous drainage, without significant
erythema or pus. He was afebrile but had a white blood cell
count of 14.6. The differential revealed 83.9% neutrophils
and 12.4% lymphocytes, with no bands. The patient was
treated for a presumptive superficial wound infection with
antibiotics for ten days with resolution of the pain and white
count.
However, despite resolution of the infection, the patient
still had a skin inflammatory change that persisted for
5 weeks following implantation (Figure 4). Because of poor

Figure 4 Persistent inflammatory reaction on the upper back (L2 level) 5 weeks
post implantation in case 2. Lead strain relief is directly under the inflammatory
tissue.
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wound healing, the decision was made to remove the dual
leads, silastic anchors with associated 0 silk sutures, and the
implantable pulse generator. Intraoperative frozen sections
revealed acute and chronic inflammation, with a foreign body
giant cell reaction (Figure 5A and B). The removal of the
soft inflammatory tissue in Figure 4 revealed the underlying
leads, and the pocket floor of the implantable pulse generator that had excess lead coils was notable for soft tissue
inflammation. Similarly, the tissue was very friable and bled
easily with manipulation. Interestingly, there was no fibrotic
tissue deposition surrounding the leads, anchors, or the floor
of the implantable pulse generator pocket. Normal wound
healing then proceeded with an uneventful recovery.

Case 3
The patient was a 40-year-old right-handed female, who
presented to the pain center with a diagnosis of complex

A

B

Figure 5 (A) Histopathologic examination of skin and soft tissue specimen taken
from the mid back (Figure 4), showing skin and subcutaneous tissue with ulceration
and necrosis, acute and chronic inflammation, and a foreign body multinucleated
giant cell reaction. (B) Arrow points to one of the many multinucleated giant cells
seen close up from tissue detailed in (A).
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regional pain syndrome affecting the right upper extremity.
This condition was believed to be the result of two right
shoulder operations for supraspinatus tendon tears. The pain
was burning diffusely across her right shoulder, extending
over her scapula and down her arm into her hand, with an
intensity of 7/10. Her past history was significant only for
asthma and sinus infections. She was allergic to nickel,
oxycodone/acetaminophen, metronidazole, scopolamine,
and tramadol. After multiple interventions including stellate and interscalene blocks, transcutaneous electrical nerve
stimulation, physical therapy, intravenous lidocaine, and
multimodal pharmacotherapy failed to bring appreciable
relief, she underwent a one-week trial of SCS. After reporting
a greater than 50% pain intensity reduction, she had a fully
implanted dual 8 contact system placed via an upper back
incision at the T2/3 level, with the implantable EON pulse
generator placed in the right buttock region. A small pocket
for lead extensions was made on the right flank just below
the bra line at the T9 level.
The patient was seen one week after implantation and all
wounds were healing well. She had reported some clear drainage from the upper back wound, but there was none noted on
examination. Her white blood cell count was within normal
range and she was afebrile. Five weeks later she called to say
that she was developing a partially opened wound at the lead
insertion site as well as the lead extension site, with copious
amounts of clear drainage. She remained afebrile without
chills, and denied a history of trauma or falls. Examination
of the wound revealed minimal erythema with no hardware
exposure but it had grossly evident soft tissue inflammation.
Her white blood cell count was 8.7 but she had an erythrocyte
sedimentation rate of 53 and a C-reactive protein of 11.8.
Because of persistent wound inflammation and intermittent clear drainage, the leads, silastic anchors (associated
0 Ethibond sutures, Ethicon Inc), and lead extensions were
removed 7 weeks post implantation. The clinical plan was
to reinsert the leads at a lower level if it was proven to be
less immunoreactive using the methods described in case 1.
Figure 6A and B displays the histology of the specimen
results sent from the upper back wound. The wounds healed
rapidly with removal of the leads and anchors.
One month after removal of the leads, the patient called
to report a minor amount of bleeding from the buttock wound
where the implantable pulse generator had been implanted.
She reported no falls or trauma. On examination, the buttock
wound had progressed to early dehiscence with clear drainage.
She was afebrile and her white blood cell count was 8.1,
erythrocyte sedimentation rate was 45, and C-reactive protein
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A

B

Figure 6 (A) Histopathology results for a specimen taken from the T2/3 level of
the back (lead insertion wound). Microscopic analysis reveals granulation tissue with
hemorrhage, acute and chronic inflammation, and a focal foreign body giant cell
reaction. (B) Arrow points to multinucleated giant cell seen close up from tissue
detailed in (A).

was 13.8. The implantable pulse generator was subsequently
removed at approximately 11 weeks post implantation. An
inflammatory reaction of the pocket floor was noted with
very friable tissue (Figure 7). The fibrous floor of the pocket
that is usually well formed at 3 months post-implantation was
disrupted by inflammation. There were no signs of purulence
or infection. A week later, all her wounds were healing well
and the drainage had ceased from the buttock.

Discussion
Allergic or other inflammatory reactions to the components
of spinal cord stimulation systems have only rarely been
reported.6–8 A search of the literature revealed only one
recent detailed case series to our knowledge, ie, a report
from France describing two cases of cutaneous eruption
related to spinal cord stimulators.6 The first of these cases
was a foreign body type reaction to the silicone component

Journal of Pain Research 2013:6

Figure 7 Open wound of the right buttock with implantable pulse generator. The
floor of the pocket has modest fibrous tissue with a collection of friable reactive
tissue.

of the neurostimulatory electrodes, with histology of the
affected tissue showing a foreign body granuloma formation. A similar foreign body granuloma reaction occurred
after device removal at the surgical scar, in response to
silicone particles. The second case was that of a contact
dermatitis reaction thought to be due to the silicone part of
the stimulator, with histology of affected tissue showing a
contact dermatitis pattern. Delayed hypersensitivity patch
testing confirmed a specific sensitivity to silicone.
While reports of inflammatory reactions to spinal cord
stimulator devices are exceedingly rare, reactions to other
devices, such as pacemakers and cardiac defibrillators,
have been reported less rarely.9 The apparent higher rate
of inflammatory reaction to cardiac rhythm management
devices compared with SCS may in part relate to the fact
that the former has a higher implantation rate. Two types of
delayed inflammatory responses might occur in response to
implanted devices, ie, delayed hypersensitivity responses
to a specific antigen (eg, the metal polyurethane or silicone
rubber of a device) or foreign body giant cell granuloma
reactions to device material(s). Delayed hypersensitivity responses to an allergen are mediated by T cells and
monocytes/macrophages, rather than antibodies. Contact
dermatitis is a form of delayed hypersensitivity reaction
to antigen at the surface of the skin, but a similar process
can occur to substances inoculated intradermally or subdermally. The patient in case 1 developed such a reaction
likely to the polyurethane lead extensions because the rash
was along the entire length of their course. This rash was
treated successfully with topical hydrocortisone, but the
patient presented within 2 weeks with wound dehiscence
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predisposing to early infection as suggested by the cultures
and inflammatory histology. We suspect that the proximity
of hydrocortisone treatment to the healing wounds coupled
with an inflammatory reaction likely reduced the tensile
strength, leading to dehiscence. While contact dermatitis
presented approximately one month after implantation, it
may present as soon as 8 days, as recently reported after
implantation of a peripheral nerve stimulator.10
For contact dermatitis (delayed hypersensitivity reactions to items on the surface of the skin), patch testing is
a diagnostic technique that can be utilized. This involves
placing a suspected substance on the surface of the skin for
48 hours, then looking for an inflammatory response of the
skin at 48–96 hours. While this technique can be helpful in
some cases, even with contact dermatitis, there can be false
negatives and false positives. There is little known about
whether patch testing can predict responses to a device that
is implanted subcutaneously. The immune system response
that occurs with absorption of an allergen from the surface
of the skin through the epidermis can be different from that
which occurs when the same substance is implanted. The
literature provides little insight on the reliability of patch testing to predict an inflammatory response to implanted devices.
Because of the authors’ prior experience of false negatives
on skin patch testing and the aforementioned complications
of case 1, it was thought necessary to try an “in vivo” test
of a piece of lead extension in another site for placement of
the implantable pulse generator (Figure 3). Interestingly, this
2-month test of implantation of the lead extension fragment in
the buttock region did not result in any reaction, and the device
was successfully implanted. We are unable to explain why
an inflammatory dermatitis occurred in the flank/abdominal
region but was absent in the back and buttock area.
In addition to contact dermatitis, a delayed hypersensitivity reaction may manifest as a granuloma, as reported in the
French case series. With delayed hypersensitivity reactions,
an antigen is taken up by macrophages or monocytes and is
then presented to T cells which can specifically recognize that
antigen (ie, there is memory from previous exposure to the
antigen). This leads to recruitment of further inflammatory
cells to the area, including macrophages that can in turn
form giant cells. Overall, this inflammatory pattern involving T cells and macrophages is referred to as a granuloma.
A foreign body reaction can invoke a similar inflammatory pattern, but it is not in response to a particular immunologically recognized antigen. The inflammatory reaction in
response to a foreign body starts as the body tries to respond
to the foreign substance by attempting to clean the substance
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out from the body. Neutrophils and macrophages attempt to
phagocytose the foreign substance. Macrophages will remain
at the foreign body site for an extended period of time, and
recruit other inflammatory cells to the area via secretion of
chemokines. Granulation tissue can form at the site of the
foreign body reaction (similar to granulation tissue seen with
wound healing, but in a foreign body reaction, the healing process is unable to complete itself). Therefore, the foreign body
reaction consists of persistent inflammation, characterized by
foreign body giant cells and granulomas seen on histology.
Foreign body giant cells form when macrophages encounter
a large foreign body (such as the components of an SCS
implant). Because the macrophage cells cannot phagocytose
the foreign body, the cells fuse together to form a “giant cell”
composed of many fused macrophages. In this case series,
the histology of the affected tissue from cases 2 and 3 was
that of a foreign body giant cell reaction (Figure 5A and B,
and Figure 6A and B). In case 2, the clinical impression is
that the polyurethane leads are the likely allergens, given that
the inflammatory response was seen in the implantable pulse
generator pocket floor where the excess lead coils are placed.
However, the silicone anchors cannot be excluded. Regarding
case 3, the polyurethane-coated leads and extensions are
even more likely to be the offending stimulus, given that the
reaction was in all three wounds, including lead insertion,
lead extension, and implantable pulse generator. Component
materials, which include silicone rubber (eg, anchors), polyurethane (leads, extensions), titanium (implantable pulse
generator), and platinum/iridium (electrodes), are part of an
“allergy test kit” (St Jude Medical Neuromodulation) and can
be applied topically as a skin patch test.11 Among the current
three vendors, materials used for the components of SCS
devices are similar on account of regulation by the US Food
and Drug Administration. No further skin patch or “in vivo”
testing was pursued because, given the location of the inflammatory reaction, it was not felt that allergy testing would alter
future clinical decision-making in cases 2 and 3. All patients
who receive an implanted device develop some degree of
foreign body reaction around the device. Why some patients
but not others develop a substantial, pathologic, and clinically
detrimental level of reaction is not fully known.12,13 Interestingly, none of the three patients in this case series had a history
of prior allergies to metal, rubber, or autonomic dysfunction
to suggest predisposition to cutaneous reactions.

Conclusion
In summary, delayed inflammatory responses to the
components of SCS devices can manifest via T cell/
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monocyte-mediated delayed hypersensitivity reactions or
foreign body giant cell reactions. Contact dermatitis, granuloma formation, and foreign body reactions with giant cell
formation are possible in response to SCS devices. The role
of skin patch testing remains uncertain when testing for foreign body reactions because these occurred one month after
implantation. While the lead/extension polyurethane component is suspected as the most immunogenic source in this case
series, other materials of the SCS device cannot be excluded.
Excision of the inflamed tissue and histologic evaluation is
the key for diagnosis and distinguishing between infection
and inflammation. Infection may occur as a complication of
poor wound healing because of an underlying inflammatory
response to the component(s) of the SCS device.
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